The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus
- PMID: 11878894
- DOI: 10.1006/viro.2001.1202
The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus
Abstract
Latent infection by members of the gammaherpesvirus family is typically characterized by stable episomal maintenance of genomic viral DNA. In the case of Epstein--Barr virus (EBV), this is dependent upon binding of the Epstein-Barr nuclear antigen 1 (EBNA1) to sites which lie within the origin of plasmid replication (OriP). The recently discovered Kaposi's sarcoma-associated herpesvirus (KSHV) encodes the latency-associated nuclear antigen (LANA), which appears to be important for supporting the latent infection of human cells by KSHV. The present work describes site-specific binding of the LANA protein to multiple different elements at the left end of the genome, a region which appears to be critical for maintenance of KSHV episomes. Of the three sites, terminal LANA-binding region 4 (TLBR4) binds LANA with the highest affinity when compared to the other sites. Further characterization of this cis-acting element by mutagenesis studies indicates that the minimal TLBR4-binding sequence is represented by a 13-bp sequence 5prime prime or minute CGCCCGGGCATGG 3prime prime or minute. Furthermore, this specific binding to TLBR4 was mediated by the distal 200 amino acid C-terminus of the LANA protein.
(C)2001 Elsevier Science.
Similar articles
-
The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.Virology. 1999 Nov 25;264(2):254-64. doi: 10.1006/viro.1999.9999. Virology. 1999. PMID: 10562490
-
Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.J Virol. 2004 Jul;78(14):7299-310. doi: 10.1128/JVI.78.14.7299-7310.2004. J Virol. 2004. PMID: 15220403 Free PMC article.
-
Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.J Virol. 2004 Sep;78(18):9936-46. doi: 10.1128/JVI.78.18.9936-9946.2004. J Virol. 2004. PMID: 15331727 Free PMC article.
-
Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.Herpes. 2003 Dec;10(3):72-7. Herpes. 2003. PMID: 14759339 Review.
-
KSHV Genome Replication and Maintenance in Latency.Adv Exp Med Biol. 2018;1045:299-320. doi: 10.1007/978-981-10-7230-7_14. Adv Exp Med Biol. 2018. PMID: 29896673 Review.
Cited by
-
Human Cytomegalovirus Genomes Survive Mitosis via the IE19 Chromatin-Tethering Domain.mBio. 2020 Sep 29;11(5):e02410-20. doi: 10.1128/mBio.02410-20. mBio. 2020. PMID: 32994332 Free PMC article.
-
Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.J Virol. 2006 Apr;80(7):3445-58. doi: 10.1128/JVI.80.7.3445-3458.2006. J Virol. 2006. PMID: 16537612 Free PMC article.
-
Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism.Oncotarget. 2020 Nov 17;11(46):4224-4242. doi: 10.18632/oncotarget.27815. eCollection 2020 Nov 17. Oncotarget. 2020. PMID: 33245718 Free PMC article.
-
Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA.Cell Rep. 2024 Mar 26;43(3):113888. doi: 10.1016/j.celrep.2024.113888. Epub 2024 Feb 27. Cell Rep. 2024. PMID: 38416644 Free PMC article.
-
Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2.J Virol. 2007 Apr;81(8):4021-32. doi: 10.1128/JVI.02171-06. Epub 2007 Jan 31. J Virol. 2007. PMID: 17267510 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources